Multiple gene sequencing for risk assessment in patients with early-onset or familial breast cancer

Oncotarget
Po-Han LinChiun-Sheng Huang

Abstract

Since BRCA mutations are only responsible for 10-20% of cases of breast cancer in patients with early-onset or a family history and since next-generation sequencing technology allows the simultaneous sequencing of a large number of target genes, testing for multiple cancer-predisposing genes is now being considered, but its significance in clinical practice remains unclear. We then developed a sequencing panel containing 68 genes that had cancer risk association for patients with early-onset or familial breast cancer. A total of 133 patients were enrolled and 30 (22.6%) were found to carry germline deleterious mutations, 9 in BRCA1, 11 in BRCA2, 2 in RAD50, 2 in TP53 and one each in ATM, BRIP1, FANCI, MSH2, MUTYH, and RAD51C. Triple-negative breast cancer (TNBC) was associated with the highest mutation rate (45.5%, p = 0.025). Seven of the 9 BRCA1 mutations and the single FANCI mutation were in the TNBC group; 9 of the 11 BRCA2, 1 of the 2 RAD50 as well as BRIP1, MSH2, MUTYH, and RAD51C mutations were in the hormone receptor (HR)(+)Her2(-) group, and the other RAD50, ATM, and TP53 mutations were in the HR(+)Her2(+) group. Mutation carriers were considered as high-risk to develop malignancy and advised to receive cancer screenin...Continue Reading

References

Jul 19, 2002·American Journal of Medical Genetics·Alfred G Knudson
Jun 1, 2004·Twin Research : the Official Journal of the International Society for Twin Studies·Isabella LocatelliAnatoli I Yashin
Jul 21, 2004·Journal of Computational Chemistry·Eric F PettersenThomas E Ferrin
Nov 23, 2005·Bioinformatics·Konstantin ArnoldTorsten Schwede
Mar 22, 2006·International Journal of Cancer. Journal International Du Cancer·Athena MatakidouUNKNOWN GELCAPS Consortium
Oct 25, 2006·Breast Cancer Research and Treatment·Jana ProkopcovaPetr Pohlreich
May 3, 2008·Cancer Research·Daniel J FarrugiaFergus J Couch
Oct 28, 2008·Human Mutation·Sharon E PlonUNKNOWN IARC Unclassified Genetic Variants Working Group
May 20, 2009·Bioinformatics·Heng Li, Richard Durbin
Jun 10, 2009·Bioinformatics·Heng LiUNKNOWN 1000 Genome Project Data Processing Subgroup
Apr 1, 2010·Nature Methods·Ivan A AdzhubeiShamil R Sunyaev
Jul 6, 2010·Nucleic Acids Research·Kai WangHakon Hakonarson
Sep 13, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Shadia JalalJohn J Turchi
Sep 21, 2011·Cancer·Yonglan ZhengOlufunmilayo I Olopade
Jan 24, 2012·Gynecologic Oncology·Kathryn P Pennington, Elizabeth M Swisher
Oct 24, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Christoph EngelHans F A Vasen
Feb 7, 2013·CA: a Cancer Journal for Clinicians·Carol DeSantisAhmedin Jemal
Feb 26, 2014·BMC Systems Biology·Takahiro MimoriMasao Nagasaki
Apr 16, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Allison W KurianJames M Ford
Jul 18, 2014·Annals of Surgical Oncology·David Euhus
Aug 8, 2014·The New England Journal of Medicine·Antonis C AntoniouMarc Tischkowitz
Sep 6, 2014·Journal of the National Comprehensive Cancer Network : JNCCN·Mary B DalyUNKNOWN National comprehensive cancer network
Dec 3, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Fergus J CouchPeter A Fasching

❮ Previous
Next ❯

Citations

Mar 24, 2018·BMC Cancer·Yong Alison WangAn-Suei Yang
Aug 24, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Steven M Sorscher
Jan 13, 2018·Future Oncology·Xifeng YinBinghai Chen
May 5, 2018·International Journal of Cancer. Journal International Du Cancer·Cong FanYuntao Xie
Sep 16, 2017·Advances in Anatomic Pathology·Lien N Hoang, Blake C Gilks
Sep 29, 2020·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Gabriel BandeiraOswaldo Keith Okamoto
Sep 6, 2020·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Emilia Rogoża-JaniszewskaTadeusz Dębniak
Nov 3, 2017·Hereditary Cancer in Clinical Practice·Wenjing JianXianming Wang
May 16, 2017·Annual Review of Genomics and Human Genetics·Payal D Shah, Katherine L Nathanson
Sep 21, 2018·JCO Precision Oncology·Arielle L HeekeClaudine Isaacs
Jan 11, 2020·Frontiers in Oncology·Javier OliverFelipe Vaca Paniagua
Aug 21, 2019·Frontiers in Oncology·Gulnur ZhunussovaLeyla Djansugurova
May 13, 2018·International Journal of Cancer. Journal International Du Cancer·Jun-Yan LiJun Jiang
Jul 6, 2021·Frontiers in Genetics·Neus Font-PorteriasDavid Comas
Jul 9, 2021·Frontiers in Molecular Biosciences·Jiasheng ChianSan Ming Wang
Aug 20, 2021·Journal of Maxillofacial and Oral Surgery·S Vinod NairRavindran Ankathil

❮ Previous
Next ❯

Methods Mentioned

BETA
prophylactic surgery
electrophoresis
Exome sequencing
PCR

Software Mentioned

HaplotypeCaller
Polyphen2
UCSF Chimera
GATK
GVGD align
SWISS
MODEL
align GVGD
SAMtools
SIFT

Related Concepts

Related Feeds

Cancer Sequencing

Several sequencing approaches are employed to understand and examine tumor development and progression. These include whole genome as well as RNA sequencing. Here is the latest research on cancer sequencing.

Breast Cancer Triple-N

Breast cancer cells have receptors for estrogen, progesterone, HER2 receptors (also called ERBB2). Triple-negative breast cancers do not have any of these receptors. Here are the latest discoveries pertaining to triple-negative breast cancers.

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.

Ataxia telangiectasia

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.

Breast Cancer: Risk Factors

Breast cancer is a multifactorial disease that is influenced by both environmental and genetic factors. Discover the latest research on the environmental and genetic risk factors for breast cancer here.

Ataxia telangiectasia (MDS)

Ataxia telangiectasia is a rare neurodegenerative diseases caused by defects in the ATM gene, which is involved in DNA damage recognition and repair pathways. Here is the latest research on this autosomal recessive disease.